As we approach the end of the year, here are the Top 11 Artificial Intelligence (“AI”) posts on the Debevoise Data Blog in 2024 by page views. If you are…
Artificial Intelligence
As we approach the end of the year, here are the Top 11 Artificial Intelligence (“AI”) posts on the Debevoise Data Blog in 2024 by page views. If you are…
On April 26, 2024, the Federal Trade Commission (the “FTC”) issued a controversial final rule (the “Final Rule”) that, among other things, expands the scope of the Health Breach Notification…
We have previously written about the legal risks that companies face if they oversell the capabilities of their AI systems, known as “AI washing.” In particular, the FTC and the…
On May 10−12, 2023, the National Association of Attorneys General (the “NAAG”) held its Spring 2023 Consumer Protection Conference to discuss the intersection of consumer protection issues and technology. During…
On Tuesday, May 16th, 2023, Andrew Bab of the Mergers & Acquisitions and Private Equity Groups and Co-Chair of the Healthcare & Life Sciences Group, Avi Gesser of the Data…
On February 27, 2023, the FTC released guidance entitled “Keep Your AI Claims in Check” (“AI Claims Blog Post”), reminding companies that false or unsubstantiated claims about a product’s efficacy…
As we wrote in previous posts, on August 11, 2022, the Federal Trade Commission (the “FTC”) announced its Advance Notice of Proposed Rulemaking (the “ANPR”) seeking public comment on 95 questions focused on harms…
As we noted in previous posts, on August 11, 2022, the Federal Trade Commission (“FTC”) announced its Advance Notice of Proposed Rulemaking (“ANPR”) seeking public comment on 95 questions focused…
On August 11, 2022, the Federal Trade Commission (the “FTC”) announced its Advance Notice of Proposed Rulemaking (the “ANPR”) seeking public comment on 95 questions focused on harms stemming from…
On August 11, 2022, the Federal Trade Commission (“FTC”) announced its Advance Notice of Proposed Rulemaking (“ANPR”) seeking public comment on 95 questions focused on purported harms stemming from “commercial…